Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects-Reference-Cited by-同舟云学术

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects

Published:2017-03-31 Issue:6 Volume:13 Page:1338-1345
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Shi Nianmin¹,Zhang Yibin²,Zheng Huizhen³,Zhu Zhenggang⁴,Wang Dingming⁵,Li Sihai⁶,Li Yuhua⁷,Yang Liqing¹,Zhang Junnan¹,Bai Yunhua¹,Lu Qiang¹,Zhang Zheng¹,Luo Fengji¹,Yu Chun⁵,Li Li¹

Affiliation:

1. Chaoyang District Center for Disease Control and Prevention, Beijing, P.R. China

2. Liaoning Chengda biological Limited by Share Ltd, Shenyang, P.R. China

3. Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, P.R. China

4. Wuhan City Center for Disease Control and Prevention, Wuhan, P.R. China

5. Guizhou Provincial Center for Disease Control and Prevention, Guiyang, P.R. China

6. Hunan Provincial Center for Disease Control and Prevention, Changsha, P.R. China

7. National Institutes for Food and Drug Control, Beijing, P.R. China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1279770

Reference31 articles.

1. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis

2. WHO Expert consultation on rabies: first report. WHO technical report series, 931. Geneva Switzerland: World Health Organization 2005.

3. National Health and Family Planning Commission of the People's Republic of China. Available at: http://www.nhfpc.gov.cn/.

4. The Spatial and Temporal Dynamics of Rabies in China

5. Rabies trend in China (1990–2007) and post-exposure prophylaxis in the Guangdong province

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10–60 year-old demographic;Vaccine;2024-10

2. Study on immune persistence of the CTN-1V strain rabies vaccine in humans;Journal of Virus Eradication;2024-03

3. Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study;Human Vaccines & Immunotherapeutics;2023-01-02

4. Historical Progression from Nerve Tissue-Based Rabies Vaccines to Recombinant Biologics for Humans and Companion Animals;History of Rabies in the Americas: From the Pre-Columbian to the Present, Volume I;2023

5. Analysis of Factors Influencing the Course of Rabies Vaccinations: One Year Study on Compliance of Rabies Vaccination Regimens in Haidian District of Beijing;Patient Preference and Adherence;2022-10